EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudieOpen Access · CC BY 4.0

Comparative Effectiveness of Recombinant Human Follicle-Stimulating Hormone:Recombinant Human Luteinizing Hormone in a 2:1 Ratio versus Highly Purified Human Menopausal Gonadotropin Alone in Ovarian Stimulation for Medically Assisted Reproduction Treatment Using in vitro Fertilization/Intracytoplasmic Sperm Injection: A Systematic Review and Meta-Analysis

Michael H Dahan, Juan-Enrique Schwarze, Shiv Shanker Gupta, Brooke Hayward, Robert Fischer, Sandro C Esteves, Ming-Jer Chen, Kaylen M Silverberg, Luis Guzmán, Daniele Santi, Ido Feferkorn, Thomas M D'Hooghe und 1 weitere

Gynecologic and Obstetric Investigation · 23.02.2026 · 1-14

DOI: 10.1159/000550420 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Gynecologic and Obstetric Investigation, online erschienen am 23.02.2026. Verfasst von Michael H Dahan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, McGill University, Montreal, Québec, Canada, thedoctormichaeldahan@gmail.com. Hauptthemen laut MEDLINE: Ovulation Induction, Menotropins, Luteinizing Hormone, Sperm Injections, Intracytoplasmic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Investigation of the number of oocytes recovered from different ovarian stimulation (OS) protocols is essential, as oocyte number is positively associated with the number of good-quality embryos obtained; however, there are few data comparing the number of oocytes retrieved following OS with recombinant or urinary gonadotropins.

Methods

A systematic review and meta-analysis of published evidence was performed to compare the number of oocytes retrieved with recombinant human follicle-stimulating hormone:recombinant human luteinizing hormone (r-hFSH:r-hLH) in a 2:1 ratio versus highly purified human menopausal gonadotropin (HP-hMG) alone from day 1 of OS. The literature search was conducted according to PRISMA guidelines (https://www.prisma-statement.org/) using Medline, EMBASE, Biosis, SciSearch, and TOXCENTER on STN. Studies were included if they reported on r-hFSH:r-hLH in a 2:1 ratio versus HP-hMG alone, both administered from day 1 of OS, and the results for the number of oocytes retrieved were presented for both interventions. Data were extracted from the full articles independently by two reviewers (J.-E.S. and B.H.). Results were analyzed using a random-effects meta-analysis model. Any potential risk of bias was assessed using the ROBINS-I tool. Secondary outcomes were the number of mature (MII) oocytes, clinical pregnancy rate, ongoing pregnancy rate, and live birth rate.

Results

Six studies were included in the meta-analysis (5,287 cycles): four non-interventional studies, one non-interventional cross-over study, and one randomized controlled trial. The number of oocytes per cycle was significantly higher in women treated with r-hFSH:r-hLH 2:1 compared with those treated with HP-hMG alone (mean difference 1.43, 95% confidence interval [CI]: 0.18–2.69; p = 0.025). Clinical pregnancy rate per started cycle was significantly higher with r-hFSH:r-hLH 2:1 compared with HP-hMG (rate ratio 1.18, 95% CI: 1.06–1.33; p = 0.004; five studies). There were insufficient data to draw any firm conclusions on the other secondary outcomes.

Conclusions

The higher number of oocytes retrieved with r-hFSH:r-hLH is a pertinent finding, owing to the well-established positive association between oocyte number and reproductive outcomes. Although we report a higher clinical pregnancy rate for r-hFSH:r-hLH 2:1, limited data prevented us from drawing firm conclusions regarding live birth outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovulation InductionMenotropinsLuteinizing HormoneSperm Injections, IntracytoplasmicFertilization in VitroFollicle Stimulating Hormone, HumanFollicle Stimulating HormoneHumansFemalePregnancyRecombinant ProteinsOocyte RetrievalPregnancy Rate

Stichwörter der Autor:innen

Clinical pregnancy rateHighly purified human menopausal gonadotropinMeta-analysisOocyte numberRecombinant human follicle-stimulating hormoneRecombinant human luteinizing hormoneSystematic review

Substanzen

MenotropinsLuteinizing HormoneRecombinant ProteinsFollicle Stimulating Hormone, HumanFollicle Stimulating Hormone

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, McGill University, Montreal, Québec, Canada, thedoctormichaeldahan@gmail.com.
  • Merck Healthcare KGaA, Darmstadt, Germany.
  • Hayward Ro Consulting, LLC, Ellicott City, Maryland, USA.
  • Fertility Centre Hamburg, Hamburg, Germany.
  • ANDROFERT - Andrology and Human Reproduction Clinic, Campinas, Brazil.
  • Faculty of Health, Aarhus University, Aarhus, Denmark.

Zitieren

APA

Dahan, M. H., Schwarze, J. E., Gupta, S. S., Hayward, B., Fischer, R., Esteves, S. C., Chen, M. J., Silverberg, K. M., Guzmán, L., Santi, D., Feferkorn, I., D'Hooghe, T. M., & Alviggi, C. (2026). Comparative Effectiveness of Recombinant Human Follicle-Stimulating Hormone:Recombinant Human Luteinizing Hormone in a 2:1 Ratio versus Highly Purified Human Menopausal Gonadotropin Alone in Ovarian Stimulation for Medically Assisted Reproduction Treatment Using in vitro Fertilization/Intracytoplasmic Sperm Injection: A Systematic Review and Meta-Analysis. Gynecologic and Obstetric Investigation, 1-14. https://doi.org/10.1159/000550420

Vancouver

Dahan MH, Schwarze JE, Gupta SS, Hayward B, Fischer R, Esteves SC, et al. Comparative Effectiveness of Recombinant Human Follicle-Stimulating Hormone:Recombinant Human Luteinizing Hormone in a 2:1 Ratio versus Highly Purified Human Menopausal Gonadotropin Alone in Ovarian Stimulation for Medically Assisted Reproduction Treatment Using in vitro Fertilization/Intracytoplasmic Sperm Injection: A Systematic Review and Meta-Analysis. Gynecologic and Obstetric Investigation. 2026:1-14. doi:10.1159/000550420

BibTeX
@article{Dahan2026,
  author = {Dahan, Michael H and Schwarze, Juan-Enrique and Gupta, Shiv Shanker and Hayward, Brooke and Fischer, Robert and Esteves, Sandro C and Chen, Ming-Jer and Silverberg, Kaylen M and Guzmán, Luis and Santi, Daniele and Feferkorn, Ido and D'Hooghe, Thomas M and Alviggi, Carlo},
  title = {Comparative Effectiveness of Recombinant Human Follicle-Stimulating Hormone:Recombinant Human Luteinizing Hormone in a 2:1 Ratio versus Highly Purified Human Menopausal Gonadotropin Alone in Ovarian Stimulation for Medically Assisted Reproduction Treatment Using in vitro Fertilization/Intracytoplasmic Sperm Injection: A Systematic Review and Meta-Analysis},
  journal = {Gynecologic and Obstetric Investigation},
  year = {2026},
  pages = {1--14},
  doi = {10.1159/000550420}
}
Kostenlos starten →